Amgen Inc
manufacturer
Amgen Inc is a manufacturer that makes prescription drugs. pharmaranks independently rates 22 of its products, with a composite rating of 3.6 out of 5 based on FDA regulatory (recall-safety) data.
Products (22)
aimovig
Erenumab-Aooe
amjevita
Adalimumab-Atto
aranesp
Darbepoetin Alfa
bkemv
Eculizumab-Aeeb
blincyto
Blinatumomab
imdelltra
Tarlatamab-Dlle
kanjinti
Trastuzumab-Anns
lumakras
Sotorasib
mvasi
Bevacizumab-Awwb
neulasta
Pegfilgrastim
nplate
Romiplostim
otezla
Apremilast
otezla xr
Apremilast
pavblu
Aflibercept-Ayyh
repatha
Evolocumab
riabni
Rituximab-Arrx
vectibix
Panitumumab
wezlana
Ustekinumab-Auub
corlanor
Ivabradine Hydrochloride
epogen/procrit
Epoetin Alfa
evenity
Romosozumab-Aqqg
neupogen
Filgrastim
Amgen Inc’s FDA recall record
Every recall the FDA has published for a product we list under Amgen Inc. A count on its own says little — a company making more products will record more recalls — so the events themselves are shown, most recent first.
- CORLANOR20260604
Presence of Foreign Substance.
- CORLANOR20260604
Presence of Foreign Substance.
- EVENITY20250421
CGMP Deviations; potential temperature excursions due to transit delays
- NEUPOGEN20250227
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
- NEUPOGEN20250227
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Reviews
No reviews yet. Be the first to write one.
Frequently asked questions
What does Amgen Inc make?
Amgen Inc makes prescription drugs. pharmaranks independently rates 22 of its products — see the full list below.
How is Amgen Inc rated?
pharmaranks gives Amgen Inc a composite rating of 3.6 out of 5, based on FDA regulatory (recall-safety) data across its products. See the source breakdown on this page.